PTGS2 and neoplasm: As a result, some scientists have investigated the usefulness of selective COX-2 inhibitors, such as SC-236 and Celecoxib, in vitro and in vivo to test whether their inhibition can sensitize tumor cells to make treatment more efficient against cancer using chemotherapy and radiotherapy.